Øyvind Skaugrud

748 total citations
8 papers, 564 citations indexed

About

Øyvind Skaugrud is a scholar working on Pharmaceutical Science, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Øyvind Skaugrud has authored 8 papers receiving a total of 564 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pharmaceutical Science, 3 papers in Pulmonary and Respiratory Medicine and 2 papers in Surgery. Recurrent topics in Øyvind Skaugrud's work include Advanced Drug Delivery Systems (7 papers), Cystic Fibrosis Research Advances (2 papers) and Drug Solubulity and Delivery Systems (2 papers). Øyvind Skaugrud is often cited by papers focused on Advanced Drug Delivery Systems (7 papers), Cystic Fibrosis Research Advances (2 papers) and Drug Solubulity and Delivery Systems (2 papers). Øyvind Skaugrud collaborates with scholars based in United Kingdom and Norway. Øyvind Skaugrud's co-authors include Trudi Aspden, Lisbeth Illum, Michael Dornish, Jonathan W. D. Mason, Nicholas S. Jones, James Lowe, David L. Kaplan, S.S. Davis, Jeremy Adler and Jan Karlsen and has published in prestigious journals such as Annals of the New York Academy of Sciences, International Journal of Pharmaceutics and Journal of Pharmaceutical Sciences.

In The Last Decade

Øyvind Skaugrud

8 papers receiving 528 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Øyvind Skaugrud United Kingdom 8 331 158 150 63 53 8 564
Jringjai Thongborisute Japan 8 461 1.4× 164 1.0× 162 1.1× 44 0.7× 21 0.4× 8 637
A. Sapin France 13 331 1.0× 139 0.9× 230 1.5× 52 0.8× 44 0.8× 24 735
Bas J. de Leeuw Netherlands 5 648 2.0× 237 1.5× 186 1.2× 58 0.9× 26 0.5× 6 855
Kesinee Netsomboon Austria 14 408 1.2× 158 1.0× 181 1.2× 56 0.9× 25 0.5× 25 669
Verena M. Leitner Austria 10 625 1.9× 192 1.2× 182 1.2× 107 1.7× 38 0.7× 11 822
Krum Kafedjiiski Austria 12 380 1.1× 162 1.0× 220 1.5× 90 1.4× 15 0.3× 13 652
J. D. Smart United Kingdom 10 641 1.9× 145 0.9× 82 0.5× 103 1.6× 77 1.5× 33 918
Harish B. Ravivarapu United States 8 269 0.8× 78 0.5× 134 0.9× 67 1.1× 28 0.5× 9 438
Byung Ho Woo United States 14 268 0.8× 339 2.1× 185 1.2× 48 0.8× 75 1.4× 21 767
Rolf J. Verheul Netherlands 12 327 1.0× 328 2.1× 231 1.5× 43 0.7× 20 0.4× 22 832

Countries citing papers authored by Øyvind Skaugrud

Since Specialization
Citations

This map shows the geographic impact of Øyvind Skaugrud's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Øyvind Skaugrud with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Øyvind Skaugrud more than expected).

Fields of papers citing papers by Øyvind Skaugrud

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Øyvind Skaugrud. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Øyvind Skaugrud. The network helps show where Øyvind Skaugrud may publish in the future.

Co-authorship network of co-authors of Øyvind Skaugrud

This figure shows the co-authorship network connecting the top 25 collaborators of Øyvind Skaugrud. A scholar is included among the top collaborators of Øyvind Skaugrud based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Øyvind Skaugrud. Øyvind Skaugrud is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Dornish, Michael, David L. Kaplan, & Øyvind Skaugrud. (2001). Standards and Guidelines for Biopolymers in Tissue‐Engineered Medical Products. Annals of the New York Academy of Sciences. 944(1). 388–397. 80 indexed citations
2.
Skaugrud, Øyvind, et al.. (1999). Biomedical and Pharmaceutical Applications of Alginate and Chitosan. Biotechnology and Genetic Engineering Reviews. 16(1). 23–40. 75 indexed citations
3.
Aspden, Trudi, Jonathan W. D. Mason, Nicholas S. Jones, et al.. (1997). Chitosan as a Nasal Delivery System: The Effect of Chitosan Solutions on in Vitro and in Vivo Mucociliary Transport Rates in Human Turbinates and Volunteers. Journal of Pharmaceutical Sciences. 86(4). 509–513. 204 indexed citations
4.
Aspden, Trudi, Lisbeth Illum, & Øyvind Skaugrud. (1997). The effect of chronic nasal application of chitosan solutions on cilia beat frequency in guinea pigs. International Journal of Pharmaceutics. 153(2). 137–146. 29 indexed citations
5.
Dornish, Michael, et al.. (1996). Alginate and chitosan: Biodegradable biopolymers in drug delivery systems. European Journal of Pharmaceutical Sciences. 4. S153–S153. 10 indexed citations
6.
Aspden, Trudi, Lisbeth Illum, & Øyvind Skaugrud. (1996). Chitosan as a nasal delivery system: evaluation of insulin absorption enhancement and effect on nasal membrane integrity using rat models. European Journal of Pharmaceutical Sciences. 4(1). 23–31. 116 indexed citations
7.
Aspden, Trudi, Jeremy Adler, S.S. Davis, Øyvind Skaugrud, & Lisbeth Illum. (1995). Chitosan as a nasal delivery system: Evaluation of the effect of chitosan on mucociliary clearance rate in the frog palate model. International Journal of Pharmaceutics. 122(1-2). 69–78. 37 indexed citations
8.
Skaugrud, Øyvind, et al.. (1993). Use of chitosan and chitosan malate as an excipient in wet granulation of three water soluble drugs. International Journal of Pharmaceutics. 98(1-3). 181–188. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026